Assessment of Platelet Function by High-Throughput Screening Light Transmission Aggregometry: Optimul Assay

Area of Science:

• Hematology
• Clinical Pathology

Background:

• Platelet function testing is crucial for diagnosing bleeding disorders and monitoring antiplatelet therapy.
• Light transmission aggregometry (LTA), the current standard, is expensive, time-consuming, lacks standardization, and requires expert interpretation.
• Variability in LTA results between laboratories hinders accurate clinical decision-making.

Purpose of the Study:

• To introduce and evaluate Optimul aggregometry, a novel 96-well plate-based method for platelet function analysis.
• To address the limitations of LTA by providing a standardized and accessible alternative.
• To enable in-depth platelet function analysis with reduced technical demands.

Main Methods:

• Optimul aggregometry uses pre-coated 96-well plates with standardized lyophilized agonist concentrations.
• The assay involves adding 40 μL of platelet-rich plasma to each well and measuring light absorbance changes on a plate shaker.
• Agonists tested include arachidonic acid, adenosine diphosphate, collagen, epinephrine, TRAP-6 amide, and U46619.

Main Results:

• Optimul aggregometry standardizes agonist concentrations, improving reproducibility.
• The method requires significantly less blood volume compared to traditional LTA.
• Platelet aggregation is determined by changes in light absorbance, allowing for quantitative analysis.
• The assay can be performed without specialized equipment or extensive investigator training.

Conclusions:

• Optimul aggregometry presents a standardized, user-friendly, and cost-effective approach to platelet function testing.
• This method overcomes key limitations of LTA, enhancing accessibility and reliability in clinical settings.
• It facilitates comprehensive platelet function analysis, supporting diagnosis and therapy monitoring.